Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Short Sarepta: DMD Drug Prognosis Is Dismal
Short Sarepta: DMD Drug Prognosis Is Dismal
Short Sarepta: DMD Drug Prognosis Is Dismal
Submitted by
admin
on October 30, 2013 - 9:35am
Source:
Seeking Alpha
News Tags:
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Headline:
Short Sarepta: DMD Drug Prognosis Is Dismal
Do Not Allow Advertisers to Use My Personal information
